Submitted by Anonymous (not verified) on 21 July 2026 - 9:10
Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 8, Status: Authorised
Source: